Onkologie. 2011:5(5):290-293

The importance of dental preparations of hematooncology patient before stem cell transplantation

Richard Pink, Petr Michl, Petr Tvrdý, Jindřich Pazdera
Klinika ústní, čelistní a obličejové chirurgie FN a LF UP Olomouc

The oral complication associated with cancer chemotherapy and hematopoietic stem cells transplantation may be prevented by excellent

dental evaluation of the patient before onkology therapy and systematic oral hygiene intervention after chemotherapy. A multidisciplinary

approach, systematic oral assessment are the most important factors in the prevention of significant complications.

Keywords: hematopoietic stem cells transplantation, oral mucosis

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pink R, Michl P, Tvrdý P, Pazdera J. The importance of dental preparations of hematooncology patient before stem cell transplantation. Onkologie. 2011;5(5):290-293.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bartáková V. Problémy stomatologického ošetřování u vybraných skupin rizikových pacientů. Čs Stomatologie 1986; 4: 255-260.
    2. Rubenstein E, Peterson D, Schubert M, et al. Clinical practice guidelines for prevention and treatment of cancer therapy - induced oral and gastrointestinal mucositis. Cancer 2004; 100: 2026-2046. Go to original source... Go to PubMed...
    3. Barasch A, Peterson DE, Tanzer JM, et al. Helium - neon laser effects on conditioning induced oral mucositis in bone marrow transplantation patients. Cancer 1995; 76: 2550-2556. Go to original source...
    4. Cowen D, Tardieu C, Schubert MM, et al. Low energy helium-neon laser in prevention oforal mucositis in patients undergoing bone marrow transplantation - results of double blind randomized trial. Ind J Radiad Oncol Biol Phys 1997; 38: 367-703. Go to original source... Go to PubMed...
    5. Miler TF, Silva A, Ferreira SM, Jabra-rizk MA, Kelley JI, Depaola LG. Efficacy of Listerine antiseptic in reducing viral contamination of saliva. J Clin Periodontol 2005; 32: 341-346. Go to original source... Go to PubMed...
    6. Minah GE, Depaola LG, Overholser CD, Miller TF, Niehaus C, Lamm RA, Ross NM, Dills SS. Effects of 6 months use of an antiseptic mouthrinse on supragingival dental plaque microflora. Journal of Clinical Periodontology 1989; 15: 347-352. Go to original source... Go to PubMed...
    7. Vokurka S, Bystřická E, Koza V, et al. The comparative effects of providone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT - results of a randomized multicentre study. Support Care Cancer 2002; 13: 554-558. Go to original source... Go to PubMed...
    8. Walker C, Clark W, Tyler K, Ross N, Dill S. Evaluation of microbial shifts following long-term antiseptic mouthrinse use. Journal of Periodontology 1997; 48: 646-649.
    9. Stone R, Quinn B, McCann S, et al. Improving oral care in transplantation quality control of oral mucositis (OM) assesment in the EBMT prospective oral mucositis audit (POMA). Bone Marrow Transplantation 2006; 37: N966.
    10. Wolfgang J. Köstler Hejna M, Catharina W, Zielinski C. Oral mucositis complicating chemoterapy and/or radioterapy: opinions for prevention and treatment. CA Cancer J Clin 2001; 51: 290-315. Go to original source... Go to PubMed...
    11. Keefe DM, Schubert MM, Elting LS, et al. Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109: 820-831. Go to original source... Go to PubMed...
    12. Perteson DE, Bensadoun RJ, Roila F. Magement of oral and gastrointestinal mucositis: ESMO Clinical Recommendations. Annals of Oncology 2009; 20: 174-177. Go to original source... Go to PubMed...
    13. Pink R, Vondráková J, Tvrdý P, Michl P. Salivary neutrophils level as an indicator of bone marrow engraftment. Biomedical papers 2009 Dec; 153(4): 263-269. Go to original source... Go to PubMed...
    14. Starosta M, Faber E. Stomatitis u nemocných po autologní transplantaci hemopoetických kmenových buněk. Praktické zubní lékařství 2000; 48: 131-136.
    15. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998; 34: 39-43. Fine, D.H. Mouthrinces as adjunct for plaque and gingivitis management. A status report for the American Journal of Dentistry 1988; 1: 259-263. Go to original source... Go to PubMed...
    16. Stockman MA, Sonis ST, Dijkstra PU, et al. Assesment oforal mucositis in clinical trials: impact oftraining on avaluators in multi-centre trial. Eur J Cancer 2005; 41: 1735-1738. Go to original source... Go to PubMed...
    17. Cascinu S, Fedeli A, Fedeli SL, et al. Oral cooling (cryotherapy), and effective treatment for prevention of 5- fluorouracil induced stomatitis. Eur. J. Cancer B. Oral Oncology 199; 30B: 234-236.
    18. Mahood DJ, Dose AN, Loprinzi CL, et al. Inhibition offluorouracil - induced stomatitis by oral cryotherapy. J Clin Oncol 1991; 9: 449-452. Go to original source... Go to PubMed...
    19. Mori T, Yamazaki R, Aisa Y, Nakazato T, Ikeda Y, Okamoto S. Brief oral cryoterapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients. Support Care Cancer 2005; 13: 266-269. Go to original source... Go to PubMed...
    20. Roche LK, Loprinzi CL, Lee JK, et al. A randomized clinical trial of two different durations oforal cryotherapy for prevention of 5-fluorouracil - related stomatitis. Cancer 1993; 72: 2234-2238. Go to original source...
    21. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590-2598. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.